Technical Data
M2825-12C
MDR Protein (MRP1, Multidrug resistance-associated protein 1, ABCC1, ATP-binding cassette sub-family C member 1, Leukotriene C(4) transporter)
Description:
Application(s):
Flow Cytometry (cell permeabilization required)
Immunocytochemistry (cytospin preparations)
Immunohistochemistry (frozen sections, weak in paraffin sections)
Western Blot
Suggested starting dilution is 1:20. Optimal conditions must be determined individually for each application.

TypeIsotypeCloneGrade
MabIgG16D556Supernatant
SizeStorageShippingSourceHost
250ug-20CBlue IceHumanMouse
Concentration:
~0.5mg/ml
Immunogen:
Recombinant human MRP1 (multidrug resistance-associated protein 1) (aa 1294-1531).
Purity:
Supernatant
Form
Liquid. Antibody in serum free culture supernatant containing 0.7% BSA and 0.1% sodium azide.
Specificity:
Recognizes the internal epitope (P1511SDLLQQRGL1520) of human MRP1, overexpressed in various human non-P-glycoprotein MDR tumor cell lines. Does not cross-react with human P-glycoprotein, MDR3 P-glycoprotein or human MRP2 (cMOAT) to MRP5.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. M.J. Flens, et al.; Cancer Res. 54, 4557 (1994) 2. G.J. Zaman, et al.; PNAS 91, 8822 (1994) 3. K. Nooter, et al.; Clin. Cancer Res. 1, 1301 (1995) 4. D. Schadendorf, et al.; Am. J. Pathol. 147, 1545 (1995) 5. M.J. Flens, et al.; Am. J. Pathol. 148, 1237 (1996) 6. K. Nooter, et al.; Ann. Oncol. 7, 75 (1996) 7. M.L. Den Boer, et al.; Leukemia 11, 1078 (1997) 8. A.G. Borg, et al.; Br. J. Haematol. 103, 1083 (1998) 9.D.R. Hipfner, et al.; Br. J. Cancer 78, 1134 (1998) 10. G.A. Meijer, et al.; J. Clin. Pathol. 52, 450 (1999)11.J.M. Sargent, et al.; Adv. Exp. Med. Biol. 457, 205 (1999) 12. R. Daoud, et al.; Biochemistry 39, 6094 (2000) 13. R. Daoud, et al.; Biochemistry 39, 15344 (2000) 14. S. Poulain, et al.; Br. J. Haematol. 110, 591 (2000) 15. A. Rosati, et al.; Anticancer Res. 20, 3403 (2000) 16. G.L. Scheffer, et al.; Cancer Res. 60, 5269 (2000)